Stock listing

Haisco Pharmaceutical Group Co. Ltd. Class A

Selected listing: 002653 · SZSE · CNY · CN

Haisco Pharmaceutical Group Co. Ltd. Class A (Shenzhen:002653), Health Technology. Latest release Apr 13, 2026: Haisco Enters into Exclusive License Agreement…

002653:SZSECNYCNUpdated October 2, 2026
Haisco Pharmaceutical Group Co. Ltd. Class A logo
Ticker
Shenzhen:002653
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Generic
Exchange
Shenzhen
Currency
CNY

About Haisco Pharmaceutical Group Co. Ltd. Class A

The company is involved in the pharmaceutical industry, focusing on the development and production of various healthcare products. Haisco aims to enhance healthcare solutions and contribute to the well-being of patients.

Latest news from Haisco Pharmaceutical Group Co. Ltd. Class A

Haisco Enters into Exclusive License Agreement with AbbVie to Develop Novel Medicines for Pain

April 13, 2026

Haisco Grants Global Rights of Innovative Drug HSK39004 to AirNexis in Deal Exceeding USD 1 Billion

January 12, 2026

All Haisco Pharmaceutical Group Co. Ltd. Class A news →

Research Haisco Pharmaceutical Group Co. Ltd. Class A

Haisco Pharmaceutical Group Co. Ltd. Class A company profile

View the public company page for Haisco Pharmaceutical Group Co. Ltd. Class A on 6ix.

Haisco Pharmaceutical Group Co. Ltd. Class A news

Read company news and market updates connected to Haisco Pharmaceutical Group Co. Ltd. Class A.

Haisco Pharmaceutical Group Co. Ltd. Class A investor events

Find investor webinars, events, and replay context for Haisco Pharmaceutical Group Co. Ltd. Class A.